{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:29:43Z","timestamp":1791401383854,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ejpb.2008.05.016","type":"journal-article","created":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T09:13:27Z","timestamp":1212830007000},"page":"711-717","source":"Crossref","is-referenced-by-count":30,"title":["Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis"],"prefix":"10.1016","volume":"70","author":[{"given":"Sara","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gamazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"San Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro","family":"Espuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2008.05.016_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4615-5855-2_46","article-title":"In situ detection of cytokines in allergic inflammation","volume":"409","author":"Hamid","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejpb.2008.05.016_bib2","unstructured":"The allergic child \u2013 optimal diagnosis by primary care physicians. Eur. Acad. Allergy Clin. Immunol. (2006). Available from: <http:\/\/www.eaaci.net\/media\/PDF\/B\/683.pdf>."},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaci.2005.05.017","article-title":"Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey","volume":"116","author":"Arbes","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.ejpb.2008.05.016_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"Moller","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2001.112027","article-title":"Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial","volume":"107","author":"Walker","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.ejpb.2008.05.016_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990\u20132001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.ejpb.2008.05.016_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.coi.2005.09.010","article-title":"Molecular design of allergy vaccines","volume":"17","author":"Linhart","year":"2005","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.ejpb.2008.05.016_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1067\/mai.2003.1337","article-title":"Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial","volume":"111","author":"Fellrath","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-8707(69)90126-9","article-title":"Induction of both reaginic and blocking antibodies with a low molecular weight fraction of timothy pollen extract","volume":"43","author":"Malley","year":"1969","journal-title":"J. Allergy"},{"issue":"13","key":"10.1016\/j.ejpb.2008.05.016_bib11","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1096\/fj.00-0888fje","article-title":"Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy","volume":"15","author":"Ganglberger","year":"2001","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm0596-540","article-title":"Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.ejpb.2008.05.016_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines \u2013 current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2008.05.016_bib14","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1166\/jnn.2006.471","article-title":"Development of a novel vaccine delivery system based on Gantrez nanoparticles","volume":"6","author":"G\u00f3mez","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physrev.00023.2001","article-title":"Dendritic cells: immune regulators in health and disease","volume":"82","author":"Lipscomb","year":"2002","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1074-7613(03)00182-1","article-title":"Dendritic cells in immunity and tolerance-do they display opposite functions?","volume":"19","author":"Moser","year":"2003","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2000.00093.x","article-title":"Toll-like receptors: molecular mechanisms of the mammalian immune response","volume":"101","author":"Brightbill","year":"2000","journal-title":"Immunology"},{"issue":"Suppl. 2","key":"10.1016\/j.ejpb.2008.05.016_bib18","article-title":"CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tactics","volume":"24","author":"Harandi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2008.05.016_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants--a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14760584.2.2.269","article-title":"Microparticles as vaccine adjuvants and delivery systems","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jconrel.2005.10.010","article-title":"Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency","volume":"110","author":"Kazzaz","year":"2006","journal-title":"J. Control. Release"},{"issue":"8\u201310","key":"10.1016\/j.ejpb.2008.05.016_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10611860410001670026","article-title":"Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses","volume":"11","author":"Diwan","year":"2003","journal-title":"J. Drug Target"},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0939-6411(02)00129-7","article-title":"The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses","volume":"55","author":"Cui","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejpb.2008.05.016_bib26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/IAI.60.4.1385-1389.1992","article-title":"Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines","volume":"60","author":"Goldstein","year":"1992","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.ejpb.2008.05.016_bib27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/IAI.13.6.1638-1641.1976","article-title":"Endotoxic activity of rough organisms of Brucella species","volume":"13","author":"Jones","year":"1976","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.43.3.779-782.1984","article-title":"Immunochemical characterization of rough Brucella lipopolysaccharides","volume":"43","author":"Moreno","year":"1984","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/IAI.57.5.1419-1426.1989","article-title":"Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis","volume":"57","author":"Gamazo","year":"1989","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejpb.2008.05.016_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1432-1033.1969.tb00601.x","article-title":"A new method for the extraction of R lipopolysaccharides","volume":"9","author":"Galanos","year":"1969","journal-title":"Eur. J. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2008.05.016_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(02)00182-5","article-title":"Quantification of the bioadhesive properties of protein-coated PVM\/MA nanoparticles","volume":"242","author":"Arbos","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2008.05.016_bib32","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0021-9258(18)69851-5","article-title":"The thiobarbituric acid assay of sialic acids","volume":"234","author":"Warren","year":"1959","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib33","first-page":"149","article-title":"Variations in antigen-specific histamine release related with immunotherapeutic treatment","volume":"17","author":"Castillo","year":"1989","journal-title":"Allergol. Immunopathol. (Madr.)"},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.intimp.2003.10.009","article-title":"The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis","volume":"4","author":"Watanabe","year":"2004","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1165\/ajrcmb.21.5.3755","article-title":"Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice","volume":"21","author":"Stampfli","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2222.1987.tb02039.x","article-title":"Effect of homogenization and pasteurization on the allergenicity of bovine milk analysed by a murine anaphylactic shock model","volume":"17","author":"Poulsen","year":"1987","journal-title":"Clin. Allergy"},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/17425247.2.5.807","article-title":"Starch microparticles as vaccine adjuvant","volume":"2","author":"Rydell","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-3659(03)00337-7","article-title":"Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy","volume":"92","author":"Batanero","year":"2003","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.ejpb.2008.05.016_bib39","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/S0264-410X(98)00179-0","article-title":"A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2","volume":"16","author":"Singh","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ejpb.2008.05.016_bib40","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1128\/IAI.73.8.5137-5143.2005","article-title":"MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus","volume":"73","author":"Weiss","year":"2005","journal-title":"Infect. Immun."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2008.05.016_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-3659(02)00276-6","article-title":"Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens","volume":"85","author":"Murillo","year":"2002","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.ejpb.2008.05.016_bib42","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1128\/IAI.67.9.4418-4426.1999","article-title":"Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway","volume":"67","author":"Agranovich","year":"1999","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.ejpb.2008.05.016_bib43","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1128\/IAI.67.12.6257-6263.1999","article-title":"Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria","volume":"67","author":"Huang","year":"1999","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib44","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/JVI.70.5.3084-3092.1996","article-title":"Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB\/c mice","volume":"70","author":"Lapham","year":"1996","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.ejpb.2008.05.016_bib45","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1128\/IAI.68.6.3290-3296.2000","article-title":"Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.ejpb.2008.05.016_bib46","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/IAI.63.7.2720-2728.1995","article-title":"Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus","volume":"63","author":"Zaitseva","year":"1995","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2003.11.025","article-title":"Immunologic influences on allergy and the TH1\/TH2 balance","volume":"113","author":"Romagnani","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2008.05.016_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000090282","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"91","author":"Akdis","year":"2006","journal-title":"Chem. Immunol. Allergy"},{"issue":"8","key":"10.1016\/j.ejpb.2008.05.016_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/thx.2003.019166","article-title":"Regulation: the art of control? Regulatory T cells and asthma and allergy","volume":"59","author":"Robinson","year":"2004","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ejpb.2008.05.016_bib50","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.4049\/jimmunol.165.9.4848","article-title":"T regulatory cells 1 inhibit a Th2-specific response in vivo","volume":"165","author":"Cottrez","year":"2000","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib51","doi-asserted-by":"crossref","first-page":"L987","DOI":"10.1152\/ajplung.00440.2005","article-title":"TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway","volume":"290","author":"Moisan","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2008.05.016_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000091162","article-title":"Prophylactic intranasal treatment with fragments of 1,3-beta-glucanase olive pollen allergen prevents airway inflammation in a murine model of type I allergy","volume":"139","author":"Palomares","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.ejpb.2008.05.016_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2004.02519.x","article-title":"Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy","volume":"137","author":"Repa","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.ejpb.2008.05.016_bib54","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.4049\/jimmunol.164.5.2701","article-title":"IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma","volume":"164","author":"Wild","year":"2000","journal-title":"J. Immunol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108001999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108001999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T23:35:29Z","timestamp":1631403329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641108001999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0939641108001999"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2008.05.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}